Your browser doesn't support javascript.
loading
Functional and pharmacological role of the dopamine D4 receptor and its polymorphic variants.
Ferré, Sergi; Belcher, Annabelle M; Bonaventura, Jordi; Quiroz, César; Sánchez-Soto, Marta; Casadó-Anguera, Verònica; Cai, Ning-Sheng; Moreno, Estefanía; Boateng, Comfort A; Keck, Thomas M; Florán, Benjamín; Earley, Christopher J; Ciruela, Francisco; Casadó, Vicent; Rubinstein, Marcelo; Volkow, Nora D.
Affiliation
  • Ferré S; Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes on Drug Abuse, Baltimore, MD, United States.
  • Belcher AM; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, United States.
  • Bonaventura J; Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes on Drug Abuse, Baltimore, MD, United States.
  • Quiroz C; Pharmacology Unit, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, L'Hospitalet de Llobregat, Spain.
  • Sánchez-Soto M; Neuropharmacology & Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research, L'Hospitalet de Llobregat, Spain.
  • Casadó-Anguera V; Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes on Drug Abuse, Baltimore, MD, United States.
  • Cai NS; Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes on Drug Abuse, Baltimore, MD, United States.
  • Moreno E; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, Spain.
  • Boateng CA; Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes on Drug Abuse, Baltimore, MD, United States.
  • Keck TM; Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona (IBUB), University of Barcelona, Barcelona, Spain.
  • Florán B; Department of Basic Pharmaceutical Sciences, Fred Wilson School of Pharmacy, High Point, NC, United States.
  • Earley CJ; Department of Chemistry and Biochemistry, Rowan University, Glassboro, NJ, United States.
  • Ciruela F; Departament of Physiology, Biophysics and Neurosciences, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico.
  • Casadó V; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • Rubinstein M; Pharmacology Unit, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, L'Hospitalet de Llobregat, Spain.
  • Volkow ND; Neuropharmacology & Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research, L'Hospitalet de Llobregat, Spain.
Front Endocrinol (Lausanne) ; 13: 1014678, 2022.
Article in En | MEDLINE | ID: mdl-36267569
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dopamine / Receptors, Dopamine D4 Limits: Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dopamine / Receptors, Dopamine D4 Limits: Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2022 Document type: Article Affiliation country: Country of publication: